Hendrik Lehnert

University of Magdeburg, Magdeburg, Sachsen-Anhalt, Germany 
"Hendrik Lehnert"
Mean distance: 14.64 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dankowski T, Schröder T, Möller S, et al. (2016) Male-specific association between MT-ND4 11719 A/G polymorphism and ulcerative colitis: a mitochondria-wide genetic association study. Bmc Gastroenterology. 16: 118
Harbeck B, Danneberg S, Rahvar AH, et al. (2016) Exploring the Impact of Short- and Long-Term Hydrocortisone Replacement on Cognitive Function, Quality of Life and Catecholamine Secretion: A Pilot Study. Applied Psychophysiology and Biofeedback
Kampmeyer D, Lehnert H, Moenig H, et al. (2016) A strong need for improving the education of physicians on glucocorticoid replacement treatment in adrenal insufficiency: An interdisciplinary and multicentre evaluation. European Journal of Internal Medicine
Schröder T, Kucharczyk D, Bär F, et al. (2016) Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis. Molecular Metabolism. 5: 283-95
Åkerström T, Maharjan R, Sven Willenberg H, et al. (2016) Activating mutations in CTNNB1 in aldosterone producing adenomas. Scientific Reports. 6: 19546
Cakiroglu F, Enders-Comberg SM, Pagel H, et al. (2015) Erythropoietin-enhanced endothelial progenitor cell recruitment in peripheral blood and renal vessels during experimental acute kidney injury in rats. Cell Biology International
Bartscht T, Rosien B, Rades D, et al. (2015) Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action. Molecular Cancer. 14: 199
Harbeck B, Lehnert H. (2015) [Therapy of osteoporosis: towards personalized treatment?]. Deutsche Medizinische Wochenschrift (1946). 140: 1672-7
Gebauer N, Biersack H, Czerwinska AC, et al. (2015) Single Nucleotide Polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with High-Dose Melphalan and Autologous Stem Cell Support. Leukemia & Lymphoma. 1-11
Åkerström T, Willenberg HS, Cupisti K, et al. (2015) Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas. Endocrine-Related Cancer. 22: 735-44
See more...